Services Match Patients With Clinical Trials
A growing number of patient-advocacy groups are playing matchmaker, linking patients to researchers who need them for clinical trials.
The move comes as a persistent shortage of volunteers has slowed trials of new treatments for cancer and other diseases, which typically involve a patient receiving a drug or a placebo. People, including healthy volunteers, also are urgently needed for studies to contribute to the overall understanding of diseases including Parkinson's and Alzheimer's, experts say.
Read the full story:
Source: The Wall Street Journal
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025